Nomura Asset Management has hired Douglas Stewart as head of distribution for EMEA and Latin America. Most recently, he served as managing director in the global strategy group at Silicon Valley Bank ...

Orthocell CEO and co-founder Paul Anderson was supremely confident the US Food & Drug Administration (FDA) would approve the company’s nerve repair device Remplir – as it did last week.

Canaccord Wealth has appointed Matthew (Matt) Wintour as its new head of international distribution. Wintour (pictured) will work to enhance Canaccord Wealth’s profile with IFAs across the crown ...

Electrical stimulation therapy, a prevalent technique in PNI treatment, entails the application of electric currents to stimulate nerve and muscle tissues, thereby facilitating nerve regeneration and ...

Orthocell has received US FDA 510(k) approval for Remplir, its flagship nerve repair product and can now start commercial distribution ... Remplir won't have to go head-to-head with a dominant ...

Orthocell receives US FDA 510(k) approval for Remplir, its flagship nerve repair product Approval enables Orthocell to start commercial distribution into US$1.6 ... That means Remplir won’t have to go ...

This finding suggests that deep optic nerve head circulation may play a role in glaucoma pathogenesis, according to the report. “The optic disc microvasculature directly supplies the lamina cribrosa, ...

But he said the bold move from the Pacific nation should embolden the Albanese government to hold its nerve and not be pushed around by Facebook owner Meta and other US tech companies that are seeking ...